{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:51:33Z","timestamp":1790365893995,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s12072-022-10437-1","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T17:03:04Z","timestamp":1666717384000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of pharmacogenetics and tacrolimus dosing in liver transplantation"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1286-8902","authenticated-orcid":false,"given":"James","family":"Fung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"key":"10437_CR1","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1111\/j.1600-6143.2010.03255.x","volume":"10","author":"P Trunecka","year":"2010","unstructured":"Trunecka P, Boillot O, Seehofer D, Pinna AD, Fischer L, Ericzon BG, et al. Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation. Am J Transpl 2010;10:2313\u20132323","journal-title":"Am J Transpl"},{"key":"10437_CR2","doi-asserted-by":"publisher","first-page":"882.e883","DOI":"10.1016\/j.clinthera.2019.03.006","volume":"41","author":"M Allard","year":"2019","unstructured":"Allard M, Puszkiel A, Conti F, Chevillard L, Kamar N, Noe G, et al. Pharmacokinetics and pharmacodynamics of once-daily prolonged-release tacrolimus in liver transplant recipients. Clin Ther 2019;41:882\u2013896.e883","journal-title":"Clin Ther"},{"key":"10437_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/86882","volume":"27","author":"P Kuehl","year":"2001","unstructured":"Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 2001;27:383\u2013391","journal-title":"Nat Genet"},{"key":"10437_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.146007","volume":"809","author":"Y Dong","year":"2022","unstructured":"Dong Y, Xu Q, Li R, Tao Y, Zhang Q, Li J, et al. CYP3A7, CYP3A4, and CYP3A5 genetic polymorphisms in recipients rather than donors influence tacrolimus concentrations in the early stages after liver transplantation. Gene 2022;809: 146007","journal-title":"Gene"},{"key":"10437_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2165\/11317550-000000000-00000","volume":"49","author":"CE Staatz","year":"2010","unstructured":"Staatz CE, Goodman LK, Tett SE. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: part II. Clin Pharmacokinet 2010;49:207\u2013221","journal-title":"Clin Pharmacokinet"},{"key":"10437_CR6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2217\/pgs.15.42","volume":"16","author":"RA Pulk","year":"2015","unstructured":"Pulk RA, Schladt DS, Oetting WS, Guan W, Israni AK, Matas AJ, et al. Multigene predictors of tacrolimus exposure in kidney transplant recipients. Pharmacogenomics 2015;16:841\u2013854","journal-title":"Pharmacogenomics"},{"key":"10437_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/tpj.2010.20","volume":"11","author":"S Laechelt","year":"2011","unstructured":"Laechelt S, Turrini E, Ruehmkorf A, Siegmund W, Cascorbi I, Haenisch S. Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function. Pharmacogenomics J 2011;11:25\u201334","journal-title":"Pharmacogenomics J"},{"key":"10437_CR8","doi-asserted-by":"crossref","unstructured":"Park J, Lee KW, Oh SC, Park MY, Lee JM, Hong SY, Hong SK, et al. Impact of single-nucleotide polymorphisms on tacrolimus pharmacokinetics in liver transplant patients after switching to once-daily dosing. Hepatol Int. 2022","DOI":"10.1007\/s12072-022-10401-z"},{"key":"10437_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1432-2277.2011.01365.x","volume":"25","author":"A Capron","year":"2012","unstructured":"Capron A, Lerut J, Latinne D, Rahier J, Haufroid V, Wallemacq P. Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study. Transpl Int 2012;25:41\u201347","journal-title":"Transpl Int"},{"key":"10437_CR10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.clinbiochem.2014.12.018","volume":"48","author":"F Lemaitre","year":"2015","unstructured":"Lemaitre F, Blanchet B, Latournerie M, Antignac M, Houssel-Debry P, Verdier MC, et al. Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells. Clin Biochem 2015;48:406\u2013411","journal-title":"Clin Biochem"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10437-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10437-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10437-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T17:45:24Z","timestamp":1675359924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10437-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10437"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10437-1","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]},"assertion":[{"value":"31 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"James Fung declares that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}